A Study of rhGAA in Patients With Late-Onset Pompe Disease

NCT00250939 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Pompe Disease (Late-onset)
Glycogen Storage Disease Type II (GSD-II)
Acid Maltase Deficiency Disease
Glycogenosis 2

Interventions

BIOLOGICAL: Myozyme

Sponsor

Genzyme, a Sanofi Company